At meeting held on 20 October 2014
Bal Pharma announced that the Board of Directors of the Company at its meeting held on 20 October 2014, inter alia, transacted the following business:- After obtaining the approvals from the members, stock exchanges and other regulatory agencies and after having received the 25% of the initial consideration amount from the subscribers, the Board has approved the issue and allotment of 13,00,000 warrants to the subscribers on preferential basis, at a conversion price of Rs.62/- per warrant.
Powered by Capital Market - Live News
